FDA Inspection 704480 — Concordia Clinical Research (IRB)
The FDA completed an inspection of Concordia Clinical Research (IRB) on Dec 30, 2010 in Cedar Knolls, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 8 citations were issued during this inspection. Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 30, 2010
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cedar Knolls, NJ (United States)
Additional details
IRB
Citations
| ID | CFR | Description |
|---|---|---|
| 7278 | 21 CFR 56.107(e) | Conflict of interest |
| 7281 | 21 CFR 56.108(a)(1) | Initial and continuing reviews |
| 7317 | 21 CFR 56.115(a)(1) | Copies of all research proposals and related documents |
| 7318 | 21 CFR 56.115(a)(2) | Minutes of IRB meetings |
| 7319 | 21 CFR 56.115(a)(3) | Records of continuing review |
| 7320 | 21 CFR 56.109(e) | IRB approvals/disapprovals - general |
| 7390 | 21 CFR 50.25(a)(4) | Alternate procedures, courses of treatment |
| 7393 | 21 CFR 50.25(a)(8) | Participation; refusal and discontinuance |